Aurora Cannabis Inc. Common Shares (ACB) is a publicly traded Healthcare sector company. As of July 10, 2026, ACB trades at $2.71 with a market cap of $166.00M and a P/E ratio of 0.00. ACB moved +1.12% today. Year to date, ACB is -36.02%; over the trailing twelve months it is -40.92%. Its 52-week range spans $2.63 to $6.91. Analyst consensus is strong buy with an average price target of $4.31. Rallies surfaces ACB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Aurora Cannabis Named First Cannabis Firm on Canada's Best Companies 2026 List: Aurora Cannabis became the first-ever cannabis company named to Canada's Best Companies 2026 list, one of only 125 firms selected after evaluation of companies with at least US$100 million in 2024–25 revenue. The ranking measured employee satisfaction, three-year positive revenue growth and transparency in sustainability reporting.
| Metric | Value |
|---|---|
| Price | $2.71 |
| Market Cap | $166.00M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.16% |
| 52-Week High | $6.91 |
| 52-Week Low | $2.63 |
| Volume | 1.40M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
4 analysts cover ACB: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $4.31.